María José
Calasanz Abinzano
Catedrática de Universidad
Publicaciones en las que colabora con María José Calasanz Abinzano (11)
2015
-
Correlation of myelodysplastic syndromes with i(17)(q10) and TP53 and SETBP1 mutations
British Journal of Haematology
2011
-
PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect
Leukemia, Vol. 25, Núm. 4, pp. 606-614
2010
-
EVI1 controls proliferation in acute myeloid leukaemia through modulation of miR-1-2
British Journal of Cancer, Vol. 103, Núm. 8, pp. 1292-1296
2006
-
ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia
Oncogene, Vol. 25, Núm. 13, pp. 1862-1870
2005
-
Pediatric meningosarcoma: Clinical evolution and genetic instability
Pediatric Neurology, Vol. 32, Núm. 5, pp. 352-354
2003
-
Secondary myelodysplastic syndrome after treatment for promyelocytic leukemia: Clinical and genetic features of two cases
Cancer Genetics and Cytogenetics, Vol. 143, Núm. 2, pp. 178-181
2002
-
Measurement and analysis of the chemotherapy-induced genetic instability in pediatric cancer patients
Mutagenesis, Vol. 17, Núm. 2, pp. 171-175
2000
-
Characteristics and value of chromosome aberrations induced by antitumor treatments in pediatric patients with cancer
Revista de medicina de la Universidad de Navarra, Vol. 44, Núm. 1, pp. 15-24
-
Nonclonal chromosomal aberrations induced by anti-tumoral regimens in childhood cancer: Relationship with cancer-related genes and fragile sites
Cancer Genetics and Cytogenetics, Vol. 121, Núm. 1, pp. 78-85
1998
-
Emergence of secondary acute leukemia in a patient treated for osteosarcoma: Implications of germline TP53 mutations
Medical and Pediatric Oncology, Vol. 30, Núm. 3, pp. 165-169